ClinicalTrials.Veeva

Menu

Diagnosis of Prader-Willi Syndrome and Angelman Syndrome

N

National Cheng-Kung University

Status

Completed

Conditions

Mental Disorder
Fetus Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT04155944
B-ER-102-155-t

Details and patient eligibility

About

In a retrospective study, data were assessed from cases regarding PWS/AS that underwent molecular diagnosis at the National Chen-Kung University Hospital, Tainan, Taiwan, between January 2001 and December 2014.

Full description

Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two distinct syndromes of developmental impairment that result from loss of the expression of imprinted genes on the q11-q13 region of chromosome 15 (15q11-q13). Approximately 70%--75% of individuals affected with PWS and AS have an interstitial deletion of 15q11-q13. Regarding the remaining individuals with PWS, maternal uniparental disomy is the cause in 20% of cases, imprinting errors in 3% of cases, and chromosomal translocation in approximately 1% of cases. Regarding the remaining cases of AS, paternal uniparental disomy accounts for 2% of cases and mutations in the UBE3A gene for 20% of cases.The PWS/AS critical region was examined by fluorescence in situ hybridization (FISH), methylation-specific PCR (M-PCR), and methylation-specific multiplex-ligation dependent probe amplification(MS-MLPA). In a retrospective study at the National Chen-Kung University Hospital,Tainan, Taiwan, data were reviewed from cases that were referred for molecular diagnosis between January 1, 2001, and December 31, 2014.

Enrollment

60 patients

Sex

All

Ages

Under 45 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Individual with clinical features related to Prader-Willi syndrome or Angelman syndrome;
  • Fetus with suspicious deletion or duplication of chromosome 15q11.2-q13 visible by the microscope;
  • Fetus whose mother or father has chromosomal abnormality involving 15q11.2-q13
  • Fetus with mosaic trisomy 15

Exclusion Criteria:

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems